Anti-Neisseria meningitidis NHBA/Dextranase Antibody (12E1#) from ProteoGenix; catalogue ARO-A23032; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The ultimate solution for combating bacterial infections.
This antibody is specifically designed to target Neisseria meningitidis, a bacteria responsible for causing meningitis, a life-threatening infection of the brain and spinal cord. It works by binding to the NHBA/Dextranase protein on the surface of the bacteria, preventing it from attaching to human cells and causing harm.
With its high specificity and potency, the Anti-Neisseria meningitidis NHBA/Dextranase Antibody (12E1#) is a powerful tool for researchers and clinicians alike. It has a wide range of applications, including diagnostics, therapeutics, and vaccine development.
In diagnostics, this antibody can be used to detect the presence of Neisseria meningitidis in patient samples, allowing for early and accurate diagnosis of meningitis. It can also be used in research to study the role of NHBA/Dextranase in bacterial pathogenesis and to develop new treatments for meningitis.
For therapeutic purposes, the Anti-Neisseria meningitidis NHBA/Dextranase Antibody (12E1#) can be used as a passive immunotherapy to treat meningitis. By neutralizing the bacteria and preventing its spread, this antibody can save lives and improve patient outcomes.
In vaccine development, this antibody can be used to identify potential vaccine candidates by targeting the NHBA/Dextranase protein, a critical component of the bacteria’s outer membrane. This information can aid in the development of effective vaccines against Neisseria meningitidis.
The Anti-Neisseria meningitidis NHBA/Dextranase Antibody (12E1#) has been extensively tested in various experimental models and has shown excellent results in inhibiting the growth and spread of Neisseria meningitidis. Its high specificity and potency make it a valuable tool for researchers and clinicians working towards eradicating bacterial infections.
Don’t let Neisseria meningitidis threaten the health and well-being of your patients. Choose the Anti-Neisseria meningitidis NHBA/Dextranase Antibody (12E1#) for reliable and effective protection against this dangerous pathogen. Order now and join the fight against meningitis.
ProteoGenix catalogue number ARO-A23032. For research use only.
Target: C2 fragment, GNA2132, Genome-derived Neisseria antigen 2132, NHBA, Neisserial heparin binding antigen, gna2132, nhba; Clonality: Monoclonal Antibody; Applications: SPR, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | SPR |
|---|---|---|---|---|---|---|---|---|---|
| C2 fragment, GNA2132, Genome-derived Neisseria antigen 2132, NHBA, Neisserial heparin binding antigen, gna2132, nhba |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
